Literature DB >> 11840159

Mammalian target of rapamycin (mTOR): pro- and anti-apoptotic.

M Castedo, K F Ferri, G Kroemer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11840159     DOI： 10.1038/sj.cdd.4400978

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  84 in total

Review 1.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

2.  A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis.

Authors:  Sutapa Sinha; Sayantani Roy; Bathula Surendar Reddy; Krishnendu Pal; Godeshala Sudhakar; Seethalakshmi Iyer; Shamit Dutta; Enfeng Wang; Pawan Kumar Vohra; Karnati Rammohan Roy; Pallu Reddanna; Debabrata Mukhopadhyay; Rajkumar Banerjee
Journal:  Mol Cancer Res       Date:  2011-02-02       Impact factor: 5.852

3.  mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.

Authors:  Xiaoyi Hu; Pier Paolo Pandolfi; Yi Li; Jason A Koutcher; Marc Rosenblum; Eric C Holland
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

4.  Cross-species withdrawal of MCL1 facilitates postpartum uterine involution in both the mouse and baboon.

Authors:  Chandrashekara Kyathanahalli; Jason Marks; Kennedy Nye; Belinda Lao; Eugene D Albrecht; Graham W Aberdeen; Peter W Nathanielsz; Pancharatnam Jeyasuria; Jennifer C Condon
Journal:  Endocrinology       Date:  2013-10-18       Impact factor: 4.736

5.  Apoptosis and autophagy as mechanisms of dinoflagellate symbiont release during cnidarian bleaching: every which way you lose.

Authors:  Simon R Dunn; Christine E Schnitzler; Virginia M Weis
Journal:  Proc Biol Sci       Date:  2007-12-22       Impact factor: 5.349

Review 6.  Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.

Authors:  Sharon S McDaniel; Michael Wong
Journal:  Neurosci Lett       Date:  2011-02-24       Impact factor: 3.046

7.  Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells.

Authors:  Edmund Chiong; I-Ling Lee; Ali Dadbin; Anita L Sabichi; Loleta Harris; Diana Urbauer; David J McConkey; Rian J Dickstein; Tiewei Cheng; H Barton Grossman
Journal:  Clin Cancer Res       Date:  2011-03-17       Impact factor: 12.531

Review 8.  Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

9.  Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.

Authors:  Valerie I Brown; Junjie Fang; Keith Alcorn; Rosalind Barr; Jenny M Kim; Robert Wasserman; Stephan A Grupp
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

10.  Nutrient withdrawal rescues growth factor-deprived cells from mTOR-dependent damage.

Authors:  Emiliano Panieri; Gabriele Toietta; Marina Mele; Valentina Labate; Sofia Chiatamone Ranieri; Salvatore Fusco; Valentina Tesori; Annalisa Antonini; Giuseppe Maulucci; Marco De Spirito; Tommaso Galeotti; Giovambattista Pani
Journal:  Aging (Albany NY)       Date:  2010-08       Impact factor: 5.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.